Stimulation of tumor necrosis factor-α release from lipopolysaccharide-prostaglandin J2 and metabolites of prostaglandin J2

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 3, 1996, Pages 185-189

  Vedin, Inger ^a,b   Wasserman, Jerzy ^a   Hammarström, Sven ^c  

^a STOCKHOLM COUNTY COUNCIL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA12 PROSTAGLANDIN J2; DICLOFENAC; DRUG METABOLITE; PROSTAGLANDIN D2; PROSTAGLANDIN J2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE ACTIVATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029959792     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90096-4     Document Type: Article

References (24)

1. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 1978; 147: 952-957
2. 2 on responses of T-cell subsets to mitogen and autologous non-T-cell stimulation. Clin Immunol Immunopathol 1984; 33: 111-122.
3. 2 effects on human suppressor cell function and on interleukin 2 function. J Immunol 1982; 129: 2469-2473.
4. Blomgren H., Hammarström S., Wasserman J., Petrini B. Prostaglandin sensitivity of the PHA-response of blood lymphocytes following radiation therapy for breast cancer. Radiother Oncol 1986; 7: 141-145.
5. Wasserman J., Hammarström S., Petrini B., Blomgren H., von Stedingk L-V., Vedin I. Effects of some prostaglandins and leukotrienes on lymphocytes, monocytes and their activity in vitro. Int Arch Allergy Appl Immunol 1987; 83: 39-43.
6. 2. Int Arch Allergy Appl Immunol 1988; 87: 388-391.
7. Patton J. S., Rice G. C., Ranges G. E., Palladino Jr M. A. Biology of the tumor necrosis factors. In: Sorg C., ed. Cytokines. Basle: Karger, 1989: 89.
8. 2. Biochem Biophys Res Commun 1986; 137: 404-410.
9. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988; 263: 5380-5384.
10. 2-induced suppression. J Immunol 1989; 142: 4346-4350.
11. 2 down-regulates the expression of tumor necrosis alpha gene by human blood monocytes. In: Advances in Prostaglandin, Thromboxane and Leukotriene Research. New York: Raven Press Ltd., 1990: 521-524.
12. Petrini B., Wolk G., Wasserman J., Vedin I., Strannegård Ö., Blomgren H., Esposti P.-L. Indomethacin modulation of monocyte cytokine release following pelvic irradiation for cancer. Eur J Cancer 1991; 27: 591-594.
13. 2 production in resting macrophages. Biochem Biophys Res Commun 1986; 136: 94-101.
14. 2, a potential antineoplastic agent. Biochem Biophys Res Commun 1982; 105: 956-964.
15. 2 derivative with potent antineoplastic and weak smooth muscle-contracting activities. Biochem Biophys Res Commun 1982; 109: 626-633.
16. 2 formed in human plasma. Proc Natl Acad Sci USA 1984; 81: 1317-1321.
17. 2 exerting cell growth inhibition. Biochem Biophys Res Commun 1985; 127: 739-745.
18. Bøyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 1983; 17: 429-436.
19. Hughes-Fulford M., Wu J., Kato T., Fukushima M. Inhibition of DNA synthesis and cell cycle by prostaglandins independent of cyclic AMP. In: Advances in Prostaglandin, Thromboxane and Leukotriene Research. New York: Raven Press, 1985: 401-404.
20. Narumiya S., Fukushima M. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther 1986; 239: 500-505.
21. 2 in nuclei. J Pharmacol Exp Ther 1987; 242: 306-311.
22. Renz H., Gong J.-H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988; 141: 2388-2393.
23. Narumiya S., Hirata N., Namba T. et al. Structure and function of prostanoid receptors. J Lipid Mediat 1993; 6: 155-166.
24. 2 and cyclic GMP. Immunobiol 1990; 182: 44-55.